UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIV

Ripamonti, Enrico; Edén, Arvid; Nilsson, Staffan; Sönnerborg, Anders; Zetterberg, Henrik; Gisslén, Magnus; (2023) Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIV. Journal of Internal Medicine , 293 (4) pp. 445-456. 10.1111/joim.13594. Green open access

[thumbnail of Journal of Internal Medicine - 2022 - Ripamonti - Longitudinal decline of plasma neurofilament light levels after.pdf]
Preview
Text
Journal of Internal Medicine - 2022 - Ripamonti - Longitudinal decline of plasma neurofilament light levels after.pdf - Accepted Version

Download (1MB) | Preview

Abstract

OBJECTIVES: This retrospective follow-up study aims to investigate the dynamic longitudinal change of plasma neurofilament light (NfL) levels after antiretroviral (ART) initiation in a cohort of people living with HIV (PWH). METHODS: We tested a convenience sample of 116 patients from the NORTHIV study. Plasma NfL levels-measured using Single molecule array (Simoa) technology-as well as other laboratory parameters, were collected at baseline, week 4, week 48, week 96, and week 144. Linear mixed-effects models were estimated to evaluate longitudinal change over time. Baseline CD4+ T-cell levels, CDC classification, and HIV RNA levels were considered. Models were adjusted by age, sex, treatment regimen, and baseline serum creatinine levels. RESULTS: Plasma NfL levels were higher at baseline, and also declined faster during the follow-up for participants with CD4+ count <100 cells/μl compared with >100 cells/μl. No significant difference was found between the CD4+ strata 100-199/μl versus 200-499/μl. Participants with CDC classification stages B and C had higher levels of plasma NfL at baseline, as well as faster decline compared with participants with stage A. No significant main effects or change over time were found in baseline HIV RNA levels, treatment regimen, or sex. CONCLUSION: Plasma NfL is a sensitive biomarker to assess ongoing CNS injury in PWH. Plasma NfL concentrations decline relatively fast following ART initiation, and then stabilize after 48 weeks. Plasma NfL concentrations are associated with CD4+ count and stage of HIV disease. No correlations were seen with different ART regimens. This article is protected by copyright. All rights reserved.

Type: Article
Title: Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIV
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/joim.13594
Publisher version: https://doi.org/10.1111/joim.13594
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: ART, CD4+, cerebrospinal fluid NfL, HIV, neuronal injury, plasma NfL
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10161398
Downloads since deposit
2,508Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item